Shockwave Medical Inc. Stock News

A well-known peer is apparently interested in acquiring the medical device maker. Shockwave produces and sells products that use sound to break up calcium in blood vessels.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Shockwave Medical (SWAV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near

Shockwave just completed its purchase of Neovasc. Proposed new payment codes would benefit Shockwave's IVL system.

A new Medicare rule could sweeten reimbursement for Shockwave Medical's systems, according to a report Tuesday that sent SWAV stock soaring. The post Why Shares Of Shockwave Medical, A Top 5% Stock, J

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Investors need to pay close attention to Shockwave Medical (SWAV) stock based on the movements in the options market lately.

Shockwave Medical's (SWAV) latest U.S. launch is expected to serve a wider patient pool.

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Palo Alto Networks stands to benefit from increasing demand for single-vendor security solutions. Duolingo has differentiated itself from the competition by making language learning fun and engaging.

When a company beats earnings estimates, investors often pile into it. But not all earnings beats are created equal.

ShockWave is a high margin and fast grower with a large addressable market. ShockWave is profitable with good cost controls, unlike many other technology peers that are growing at a breakneck pace.

This up-and-coming medical technology star is set up to deliver market-beating gains for its long-term investors.

Two new Breakout Stocks for Week 8 with better than 10% short-term upside and two Dow 30 Picks. Average cumulative returns for 2023 are +36.7% YTD. This week peak gains were in INDI +22.83% and LTRX +

Shockwave Medical tripled Wall Street's fourth-quarter profitability expectations, leading SWAV stock to surge on Friday. The post Shockwave Medical Just Tripled Profit Expectations, Delivering 991% G